ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p378.xmlSingle-Arm Longitudinal Study to Evaluate a Decision Aid for Women Offered Neoadjuvant Systemic Therapy for Operable Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p378.pdf2026-04-18Single-Arm Longitudinal Study to Evaluate a Decision Aid for Women Offered Neoadjuvant Systemic Therapy for Operable Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p359.xmlNCCN Guidelines Insights: Colon Cancer, Version 2.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p359.pdf2026-04-18NCCN Guidelines Insights: Colon Cancer, Version 2.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p352.xmlBiallelic TSC2 Mutations in a Patient With Chromophobe Renal Cell Carcinoma Showing Extraordinary Response to Temsirolimus2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p352.pdf2026-04-18Biallelic TSC2 Mutations in a Patient With Chromophobe Renal Cell Carcinoma Showing Extraordinary Response to Temsirolimushttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p370.xmlTrends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p370.pdf2026-04-18Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United Stateshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p343.xmlConcurrent BRAF/MEK Inhibitors in BRAF V600–Mutant High-Grade Primary Brain Tumors2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p343.pdf2026-04-18Concurrent BRAF/MEK Inhibitors in BRAF V600–Mutant High-Grade Primary Brain Tumorshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p342.xmlLetter to the Editor: Panax Ginseng for Cancer-Related Fatigue2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p342.pdf2026-04-18Letter to the Editor: Panax Ginseng for Cancer-Related Fatiguehttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-pxx.xmlNCCN Conference Addressed Value-Based Healthcare Models, Payer Perspectives, New NCCN Guidelines, and Other Updates in Cancer Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-pxx.pdf2026-04-18NCCN Conference Addressed Value-Based Healthcare Models, Payer Perspectives, New NCCN Guidelines, and Other Updates in Cancer Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p341.xmlStanding Together or Alone2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p341.pdf2026-04-18Standing Together or Alonehttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-pxxvii.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-pxxvii.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p387.xmlTreating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p387.pdf2026-04-18Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p412.xmlLung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p412.pdf2026-04-18Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p402.xmlMedical Care Costs Associated With Cancer in Integrated Delivery Systems2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p402.pdf2026-04-18Medical Care Costs Associated With Cancer in Integrated Delivery Systemshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p395.xmlHigh Variability in Lymph Node Counts Among an International Cohort of Pathologists: Questioning the Scientific Validity of Node Counts2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p395.pdf2026-04-18High Variability in Lymph Node Counts Among an International Cohort of Pathologists: Questioning the Scientific Validity of Node Countshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p444.xmlNCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p444.pdf2026-04-18NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screeninghttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p451.xmlBRAF-Targeted Therapy in the Treatment of BRAF-Mutant High-Grade Gliomas in Adults2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/4/article-p451.pdf2026-04-18BRAF-Targeted Therapy in the Treatment of BRAF-Mutant High-Grade Gliomas in Adults